Oticon president satisfied with FDA approval: "A huge milestone"

An approval from the US FDA for Oticon Medical's cochlear implant system Neuro can help the Danish company kick down the door to the US market for several products. The US approval might also pave the way for the products to become accessible outside the US, President Jes Olsen states.
Photo: Jens Dresling
Photo: Jens Dresling

Thursday is a happy day for Danish company Demant's bone-anchored division Oticon Medical, which has received approval for the company's cochlear implant system Neuro by the US Food and Drug Administration (FDA).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading